FDA Alerts Consumers of Nationwide Voluntary Recall of EpiPen and EpiPen Jr.

Recall initiated due to a potential the devices may contain a defective par that may result in the devices failing to activate.

FDA Alerts Consumers of Nationwide Voluntary Recall of EpiPen and EpiPen Jr.

Submitted on Mon, 04/03/2017 - 10:58

On March 31, 2017, the drug manufacturer, Mylan in coordination with the US FDA issued an expanded nationwide voluntary recall of certain lot numbers of the drug EpiPen and EpiPen Jr. Please review the announcements to verify if your family has been affected by this recall. Mylan has provided instructions on how to return the effected products and receive a replacement,